Search Results For: Drugs [clear]
All Debates
You are browsing through all debates. You can refine the results by using the drop-down boxes above. You can view more information about each debate by clicking Show Details at right.
Winning Position: Unresolved
Evaluation of Antipsychotic DrugsCurrent Status of Development of Drugs for Psychiatric DisordersHuge market demandWith the increase of people's social pressure, the number of patients is increasing year by year, and the search for efficient and safe antipsychotic drugs has become more than a dozen urgent.Strong dependence of patients on drugsPsychiatric disorders are often difficult to cure, and patients are highly dependent on medications, often requiring long-term or even lifelong medication to relieve symptoms.Large space for drug developmentFew drugs with significant breakthrough therapeutic effects have been reported, and existing therapeutic drugs have limited their use and efficacy due to safety and drug resistance issues. Therefore, there is great space for the development of drugs for psychiatric disorders.
Winning Position: Unresolved
Antimicrobial Peptides DevelopmentSome promising natural product candidates are antimicrobial peptides (AMPs) from various organisms, which represent some of the possible solutions against superbugs. Our service is to help researchers find natural AMPs, explore their mechanisms of antimicrobial activity, and optimize antimicrobial activity and minimize toxicity and production costs, using AMP as a natural model for developing novel antibiotics in the future.Antibiotic Adjuvants DevelopmentSmall molecule antibiotic adjuvants work by hindering the bacterial resistance mechanism and making the bacteria sensitive to antibiotics. We offer several services for developing potential antibiotic adjuvants, including adjuvants that inhibit the degradation of antibiotics by β-lactamases, modulate the permeability of bacterial extracellular membranes, or increase the intracellular concentration of antibiotics by inhibiting efflux.Monoclonal Antibodies Development Against SuperbugsMonoclonal antibodies can treat bacterial infections by a variety of mechanisms and are often safe and well-tolerated. Antibodies complement antibiotic therapy and have efficacy against resistant strains of bacteria. We offer services for the development of exciting next generation antibodies against superbugs, which include antibodies with different mechanisms of action and different forms of antibodies designed.Phage Therapies Development Against SuperbugsIn the context of today's progressive rise in antibiotic resistance, phages are increasingly being used to treat chronic bacterial infections that have become resistant to multiple antibiotics. We provide development services including phage discovery, isolation, characterization, cocktail design, engineering, and preclinical development programs for phage drug discovery.Developing drugs against superbugsThe development of vaccines against superbugs is an important area of research because vaccines can help prevent infections from occurring in the first place and reduce the need for antibiotics. We provide development services of vaccine against superbugs with fast turnaround times, cost-effectiveness, and unparalleled technical expertise.
Winning Position: Caulis Spatholobi Extract
1
Caulis Spatholobi Extract
The effect of Caulis spatholobi extract on the cardiovascular system. The effect of Caulis spatholobi extract on the immune system. The extract of Spatholobus spatholobi also has antioxidant, antiviral and anti-inflammatory effects. The extract of Caulis spatholobi has the functions of nourishing blood, relaxing muscles and collaterals. Spatholobus spatholobi extract can be used for menstrual disorders, blood deficiency and chlorosis, numbness and paralysis, rheumatic arthralgia, etc.More about:Spatholobi caulis